Armata Pharmaceuticals (ARMP) Total Non-Current Liabilities (2016 - 2020)
Quarterly results put Total Non-Current Liabilities at $20.7 million for Q4 2020, up 117.21% from a year ago — trailing twelve months through Dec 2020 was $20.7 million (up 117.21% YoY), and the annual figure for FY2020 was $20.7 million, up 117.21%.
Armata Pharmaceuticals has reported Total Non-Current Liabilities over the past 8 years, most recently at $20.7 million for Q4 2020.
- Total Non-Current Liabilities reached $20.7 million in Q4 2020 per ARMP's latest filing, up from $9.5 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $20.7 million in Q4 2020 and bottomed at $2.9 million in Q1 2018.
- Median Total Non-Current Liabilities over the past 5 years was $5.7 million (2018), compared with a mean of $6.6 million.
- The largest annual shift saw Total Non-Current Liabilities crashed 76.66% in 2016 before it surged 284.42% in 2019.
- Over 5 years, Total Non-Current Liabilities stood at $6.0 million in 2016, then plummeted by 47.97% to $3.1 million in 2017, then surged by 84.08% to $5.7 million in 2018, then soared by 65.87% to $9.5 million in 2019, then soared by 117.21% to $20.7 million in 2020.
- Business Quant data shows Total Non-Current Liabilities for ARMP at $20.7 million in Q4 2020, $9.5 million in Q4 2019, and $9.9 million in Q3 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 11.03 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 42,980.09 |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 95.20 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 110.28 Mn |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 5.87 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 7.32 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 4.05 Bn |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 20.66 Mn |
| Dec 31, 2019 | 9.51 Mn |
| Sep 30, 2019 | 9.94 Mn |
| Jun 30, 2019 | 12.29 Mn |
| Mar 31, 2019 | 3.50 Mn |
| Dec 31, 2018 | 5.73 Mn |
| Sep 30, 2018 | 3.61 Mn |
| Jun 30, 2018 | 3.20 Mn |
| Mar 31, 2018 | 2.92 Mn |
| Dec 31, 2017 | 3.12 Mn |
| Sep 30, 2017 | 3.62 Mn |
| Jun 30, 2017 | 4.86 Mn |
| Mar 31, 2017 | 5.33 Mn |
| Dec 31, 2016 | 5.99 Mn |
| Sep 30, 2016 | 6.16 Mn |
| Jun 30, 2016 | 6.33 Mn |